Least developed countries vs Saudi Arabia: Antiretroviral therapy coverage
Least developed countries
82.5%
in 2024
Saudi Arabia
93.0%
in 2024
Least developed countries rank
10th
Saudi Arabia rank
11th
Antiretroviral therapy coverage over time
- Least developed countries
- Saudi Arabia
How they compare
Saudi Arabia currently reports 93.0% against 82.5% in Least developed countries, a difference of 10.5%.
That makes Saudi Arabia's figure about 1.1 times Least developed countries's.
Across all 25 years both countries report, Saudi Arabia has been ahead every year.
Least developed countries ranks 10th and Saudi Arabia ranks 11th of 23 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Least developed countries | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.3% | 26.1% | 20.8% | Saudi Arabia |
| 2010s | 43.0% | 57.9% | 14.9% | Saudi Arabia |
| 2020s | 75.5% | 90.0% | 14.5% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Least developed countries or Saudi Arabia?
- Saudi Arabia, at 93.0% against 82.5% in Least developed countries as of 2024.
- What is the difference in antiretroviral therapy coverage between Least developed countries and Saudi Arabia?
- 10.5%, with Saudi Arabia ahead.
- How many years of comparable data are there for Least developed countries and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do Least developed countries and Saudi Arabia rank globally for antiretroviral therapy coverage?
- Least developed countries ranks 10th and Saudi Arabia ranks 11th of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.